Drug-drug interactions of antibiotics and psychotropic medication;Pharmakologische interaktionen von antibiotika und psychopharmaka

Psychiatrische Praxis

Volumn 25, Issue 2, 1998, Pages 57-60

  Joos, Andreas A B ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b Städtisches Krankhs Stockach ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CLOZAPINE; DOXYCYCLINE; ERYTHROMYCIN; FLURITHROMYCIN; GENTAMICIN; HALOPERIDOL; ISONIAZID; JOSAMYCIN; LITHIUM; MACROLIDE; METACYCLINE; METRONIDAZOLE; MIDECAMYCIN; PSYCHOTROPIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; SPECTINOMYCIN; TETRACYCLINE; TROLEANDOMYCIN; UNINDEXED DRUG;

DRUG BINDING; DRUG CLEARANCE; DRUG DISPOSITION; DRUG INHIBITION; DRUG INTERACTION; DRUG INTOXICATION; DRUG METABOLISM; DRUG POTENTIATION; ENZYME INDUCTION; ENZYME INHIBITION; REVIEW;

ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; METABOLIC CLEARANCE RATE; PSYCHOTROPIC DRUGS;

EID: 0031967737     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Albani, F., R. Riva, A. Baruzzi: Clarithromycin - carbamazepine interaction: a case report. Epilepsia 34 (1993) 161-162
2. Amsterdam, J. D., G. Maislin: Effect of erythrornycin on tricyclic antidepressant metabolism. J. Clin. Psychopharmacol. 11 (1991) 203-206
3. Baciewicz, A. M., T. H. Self: Isoniazid interactions. South Med. J. 78 (1985) 714-718
4. Barzaghi, N., G. Gatti, F. Crema, M. Monteleone, L. Leone, E. Perucca: Inhibition by erythromycin of the conversion of carbamazepine to its 10,11-epoxide metabolite. Br. J. Clin. Pharm. 24 (1987) 836-838
5. Borcherding, S. M., A. M. Baciewicz, T. H. Self: Update on rifampin drug interactions II. Arch. Intern. Med. 152 (1992) 711-716
6. Cederlund, H., P. Mardh: Antibacterial activities of non-antibiotic drugs. J. Antimicrob. Chemother. 32 (1993) 355-365
7. Cohen, L. G., S. Chesley, L. Eugenio, J. G. Flood, J. Fisch, D. C. Goff: Erythromycin-induced clozapine toxic reaction. Arch. Intern. Med. 156 (1996) 675-677
8. Cvisk, V., J. Molnar: Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J. Child Adolesc. Psychopharmacol. 4 (1994) 123-128
9. Dehpour, A. R., T. Samadian, F. Roushanzamir: Interaction of aminoglycoside antibiotics and lithium at the neuromuscular junction. Drugs Exptl. Clin. Res. 18 (1992) 383-387
10. Descotes, J., P. Andre, J. C. Evreux: Pharmacokinetic interactions with macrolide antibiotics. J. Antimicrob. Chemother. 15 (1985) 659-664
11. Dieperink, H., P. P. Leyssac, H. Starklint, E. Kemp: Effects of Cyclosporin A, Gentamycin and furosemide on rat renal function: a lithium clearance study. Clin. Exp. Pharmacol. Physiol. 14 (1987) 825-836
12. Dravet, C., E. Mesdjian, B. Cenraud, J. Roger: Interaction between carbamazepine and triacetylolendadomycin. Lancet 1 (1977) 810-811
13. Fichsel, H., B. Hombach, D. Lutterbeck: Interaktionen der Antikonvulsiva mit anderen Pharmaka. Monatsschr. Kinderheilk. 132 (1985) 372-374
14. Funderberg, L. G., J. E. Vertrees, J. E. True, A. L. Miller: Seizure following addition of erythromycin to clozapine treatment. Am. J. Psychiatry 151 (1994) 1840-1841
15. Grange, J. M., P. A. Winstanley, P. D. O. Davies: Clinically significant interactions with antituberculosis agents. Drug Saf. 11 (1994) 242-251
16. Halaris, A.: Antidepressant drug therapy in the elderly: enhancing safety and compliance. Int. J. Psychiatry Med. 16 (1986) 1 - 19
17. Höffler, D., R. Ferlinz, H. Steppling, P. H. Shah: Antiinfektiöse Pharmakotherapie. In: Wolf, H. P., T. R. Weihrauch: Internistische Therapie 96/97. Urban & Schwarzenberg, Wien, München, Baltimore (1996) 115-178
18. Hollweg, M., H.-P. Kapfhammer, M. Krupinski. H.-J. Möller: Psychopathologische Syndrome unter Behandlung mit Gyrasehemmern. Nervenarzt 68 (1997) 38-47
19. Jefferson, J. W.: Lithium and tetracycline. Br. J. Dermatol. 107 (1982) 370
20. Jefferson, J. W., J. H. Greist, M. Baudhuin: Lithium: interactions with other drugs. J. Clin. Psychopharmacol. 1 (1981) 124-134
21. Johnson, D. A. W.: Drug-induced psychiatric disorders. Drugs 22 (1981) 57-69
22. Joos, A. A. B., U. G. Frank, W. P. Kaschka: Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection. J. Clin. Psychopharmacol. (Feb. 1998)
23. Joos, A. A. B., F. König, U. G. Frank, W. P. Kaschka, K. E. Mörike, R. Ewald: Dose dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Pharmacopsychiatry 30 (1997) 248-252
24. Kasper, S., B. Jung: Psychiatrisch relevante Nebenwirkungen der nichtpsychopharmakologischen Pharmakotherapie. Nervenarzt 66 (1995) 649-661
25. Ketter, T. A., R. M. Post, K. Worthington: Principles of clinically important drug interactions with carbamazepine, part 1. J. Clin. Psychopharmacol. 11 (1991) 198-203
26. Kurz, H., H.-G. Neumann, P. Wollenberg, W. Forth, D. Henschler, W. Rummel: Allgemeine Pharmakologie. In: Forth, W., D. Henschler, W. Rummel: Pharmakologie und Toxikologie. BI Wissenschaftsverlag, Mannheim, Wien, Zürich (1987) 1-97
27. Lassen, E.: Effects of acute and short-time antibiotic treatment on renal lithium elimination and serum lithium levels in the rat. Acta Pharmacol. et Toxicol. 56 (1985) 273-277
28. Malt, U.: Lithiumcarbonate and tetracycline interaction. Br. Med. J. 2 (1978) 502
29. McKichan, J. J.: Proteinbinding drug displacement interactions, facts or fiction? Clin. Pharmacokin. 16 (1989) 65-73
30. Metz, D. C., H. D. Getz: Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. Dig. Dis. Sci. 40 (1995) 912-915
31. Molnar, J., N. Batho, V. Cvisk, J. Chevalier, A. Cremieux: Interaction between tricyclic psychopharmacons and some antibiotics. Acta Microbiol. Immunol. Hung. 42 (1995) 277-285
32. Nemeroff, C. B., C. L. der Vane, B. G. Pollock: Newer anti-depressants and the cytochrome P450 system. Am. J. Psychiatry 153 (1996) 311-320
33. Neuvonen, P. J., O. Pentilla, R. Lehtovaara, K. Ahio: Effect of antiepileptic drugs on the elimination of various tetracycline derivatives. Europ. J. Clin. Pharmacol. 9 (1975) 147-154
34. Ochs, H. R., D. J. Greenblatt, M. Knüchel: Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation. Br. J. Clin. Pharmacol. 16 (1983) 743-746
35. Post, R. M.: Mood disorders: somatic treatment. In: Kaplan, H. I., B. J. Sadock: Comprehensive textbook of psychiatry/6. Williams and Wilkins, Baltimore, Philadelphia (1995) 1152-1178
36. Post, R. M.: Carbamazepine. In: Kaplan, H. I., B. J. Sadock: Comprehensive textbook of psychiatry/6. Williams and Wilkins, Baltimore, Philadelphia (1995) 1964-1972
37. Preskorn, S. H.: Sudden death and tricyclic antidepressants: a rare adverse event linked to high TCA plasma levels. Nord J. Psychiatry 24 (1993) 49-55
38. Preskorn, S. H.: Reducing the risk of drug-drug interactions: a goal of rational drug development. J. Clin. Psychiatry 57 (Suppl. 1) (1996) 3-6
39. Redington, K., C. Wells, F. Petito: Erythromycin and valproate interaction. Ann. Int. Med. 116 (1992) 877-878
40. Rosenstiel von, N.-A., D. Adam: Macrolide antibiotics. Drug. Saf. 13 (1995) 105-122
41. Saint-Salvi, B., D. Trembley, A. Surjus, M. A. Lefbevre: A study of the interaction of roxithromycin with theophylline and carbamazepine. J. Antimicrob. Chemother. 20 (1987) 121-129
42. Schou, J. S., Drug interactions at (pharmacodynamically active) receptor sites. Pharmac. Ther. 17 (1983) 199-210
43. Schulz, S. C.: Schizophrenia: somatic treatment. In: Kaplan, H. I., B. J. Sadock: Comprehensive textbook of psychiatry/6. Williams and Wilkins, Baltimore, Philadelphia (1995) 987-998
44. Self, T., C. R. Corley, S. Nabban, T. Abell: Case report: interaction of rifampin and nortriptyline. Am. J. Med. Sci. 311 (1996) 80-81
45. Waite, N. M., M. J. Rybak, D. J. Krakovsky, J. D. Steinberg, L. H. Warbasse, D. J. Edwards: Influence of subject age on the inhibition of oxidative metabolism by ciprofloxacin. Antimicrob. Agents. Chemother. 35 (1996) 130-143
46. Vincon, G., H. Albin, F. Demotes-Mainard, M. Guyot, C. Bistue, P. Loiseau: Effects of josamycin on carbamazepine kinetics. Eur. J. Clin. Pharmacol. 32 (1987) 321-323
47. Welling, P. G.: Interactions affecting drug absorption. Clin. Pharmacokint. 9 (1984) 404-434
48. Wolfersdorf, M., B. Müller-Oerlinghausen: Gyrasehemmer, Depressivität und Suizidalität. Nervenarzt (eingereicht 1997)
49. Wright, J. M., E. F. Stokes, V. P. Sweeney: Carbamazepine intoxication due to isoniazid. Clin. Invest. Med. 4 (1981) 7b